Teva Offers To Post $500M Bond For Stay On Copaxone Order
By Brian Mahoney ( April 17, 2014, 6:15 PM EDT) -- Teva Pharmaceuticals Inc. told the U.S. Supreme Court on Thursday that it is willing to post a $500 million bond if the high court temporarily restores a lower court injunction blocking two generic-drug companies from launching versions of its lucrative multiple sclerosis drug Copaxone....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.